STRS Ohio’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

STRS Ohio’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,300	Closed	-$10K	–	2491
2021 Q1	$10K	Buy	+1,300	New	+$13.6K	﹤0.01%	2129

Other funds holding SCPS

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

STRS Ohio's SCPS Position: Q2 2021 in Review

STRS Ohio sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q2 2021, closing a stake of 1,300 shares — an estimated $10K sold.

STRS Ohio first reported a position in SCPS in Q1 2021 and held it in 1 quarter. The position peaked at $10K in Q1 2021. 15 funds tracked by Wall St. Rank hold SCPS as of Q2 2021.

STRS Ohio reported no remaining Scopus BioPharma Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
STRS Ohio sold 1,300 Scopus BioPharma Inc. Common Stock shares in Q2 2021, an estimated $10K.
STRS Ohio first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 1 quarter.
STRS Ohio's Scopus BioPharma Inc. Common Stock position peaked at $10K in Q1 2021.
15 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.